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Abstract 
Cardiovascular disease is a leading cause of death worldwide, hypercholesterolemia is one of the causes. Three 
medicinal forest plants are potential natural resources to be developed as cholesterol-reducing herbal product, but 
scientific informations on their mechanism is still limited. The objective of this research is to explore the potency 
of the leaf of Jati Belanda (Guazuma ulmifolia), Jabon (Antocephalus macrophyllus), and Mindi (Melia azedarach) 
as inhibitor of HMG-CoA reductase (HMGR), a key enzyme in the regulation of cholesterol biosynthesis. 
Samples were macerated in ethanol 96% and the filtrate was partitioned using n-hexane and chloroform to obtain 
the ethanolic flavonoid extract. The effect of each extracts on the HMG-CoA reductase activity were analyzed 
using HMGR assay kit. At concentration of 10 ppm the G.ulmifolia ethanolic extract showed the highest 
inhibitory activity as well as pravastatin control inhibitor.  The phenolic content of the ethanolic extracts of 
G.ulmifolia, A.macrophyllus, and M.azedarach were: 11.00, 34.83, and 13.67 mg gallic acid AE/g dried leaves, 
respectively. The flavonoid content of the ethanolic extracts of G.ulmifolia, A.macrophyllus, and M.azedarach 
were: 0.22, 0.64, and 0.78 mg QE/g dried leaves, respectively. Interestingly, G.ulmifolia extract the lowest 
concentration of phenolic and flavonoid content. HPLC analysis showed that all samples contain quercetin at 
similiar small concentrations (6.7%, 6.6%, and 7.0% for G.ulmifolia, A.macrophyllus, and M.azedarach, 
respectively). This indicating other active compounds may play some roles in this inhibitory action on HMG-CoA 
reductase activity. Further identification using LC-MS/MS showed that G.ulmifolia flavonoid extract contained 
an unidetified coumpound with molecural weight of 380.0723 Da. 
Keywords:  G. ulmifolia; A. macrophyllus; M.azedarach; HMG-CoA reductase inhibitor; in vitro assay 
 
Abstrak 
Penyakit kardiovaskular adalah penyebab utama kematian di dunia, kondisi hiperkolesterolemia (tingginya 
kolesterol darah) adalah salah satu penyebab dari penyakit kardiovaskular. Tiga tumbuhan hutan berkhasiat 
obat diketahui memiliki potensi untuk dikembangkan sebagai produk herbal penurun kolesterol, tetapi informasi 
ilmiah tentang mekanismenya masih terbatas. Tujuan dari penelitian ini adalah untuk mengeksplorasi potensi 
dari daun Jati Belanda (Guazuma ulmifolia), Jabon (Antocephalus macrophyllus), dan Mindi (Melia azedarach) 
sebagai inhibitor HMG-CoA reductase (HMGR), enzim kunci dalam regulasi biosintesis kolesterol. Sampel 
dimaserasi dalam etanol  96% dan filtrat dipartisi menggunakan n-heksana dan kloroform untuk mendapatkan 
ekstrak flavonoid etanol. Pengaruh setiap ekstrak pada aktivitas HMGR dianalisis menggunakan HMGR assay kit. 
Sampel G.ulmifolia pada konsentrasi 10 ppm menunjukkan daya inhibisi tertinggi (82.6% inhibisi). Total fenolik 
dari sampel G.ulmifolia, A.macrophyllus, dan M.azedarach berturut-turut adalah 11.00, 34.83, dan 13.67 mg 
asam galat/g kering. Total flavonoid dari sampel G.ulmifolia, A.macrophyllus, dan M.azedarach berturut-turut 
sebesar 0.22, 0.64, dan 0.78 mg kuersetin/g kering. Menariknya, sampel G.ulmifolia memiliki kadar terendah 
baik total fenolik maupun total flavonoidnya. Analisis HPLC menunjukkan bahwa semua sampel mengandung 
kuersetin pada konsentrasi rendah (6.7%, 6.6%, dan 7.0%; berturut-turut untuk G.ulmifolia, A.macrophyllus, 
dan M.azedarach). Hal ini menunjukkan ada senyawa aktif lainnya (selain kuersetin) yang mungkin memainkan 
beberapa peran dalam aksi penghambatan aktivitas HMGR. Identifikasi lebih lanjut dengan menggunakan 
LC-MS/MS menunjukkan bahwa sampel G.ulmifolia mengandung senyawa aktif lain dengan berat molekul 
380.0723 Da. 
Kata kunci:  Jati belanda; jabon; mindi; inhibitor HMG-CoA reductase; asai in vitro 
 
Artikel Riset 
DOI :10.22435/jki.v7i2.6279.95-104 
Jurnal Kefarmasian Indonesia 
Vol.7 No.2-Agustus 2017:95-104 
         p-ISSN: 2085-675X 
e-ISSN: 2354-8770 
Jurnal Kefarmasian Indonesia. 2017;7(2):95-104 
 
96 
 
INTRODUCTION 
Cardiovascular disease is a leading 
cause of death worldwide. About 17.5 
million people die from cardiovascular 
disease in 2012 (WHO 2016).
1
 Riset 
kesehatan dasar (Riskesdas) from Ministry 
of Health of the Republic of Indonesia 
(2013) reports that the prevalence of 
coronary heart disease and stroke in 
Indonesia is based on a doctor's diagnosis 
or symptoms of 0.5% and 1.5%, 
respectively.
2
 
In Indonesia, various medicinal plants 
have been used over many generations as 
traditional remedies for cardiovascular 
disorders. Unfortunately, only a few 
scientific studies have been conducted to 
explore the potential of some medicinal 
forest plants as cholesterol reducing natural 
product, particularly based on their 
mechanism of action.    
Presently, the active component of the 
commercially available natural product for 
reducing blood cholesterol is  statin, which 
acts as HMG-CoA reductase (HMG-CoA 
reductase is an oxydoreductase enzyme, so 
it is estimated that this enzyme can be 
inhibited by compounds that have 
antioxidant activity) inhibitor. When 
administered in long-term period, however, 
some side effects were reported such as 
nausea, diarrhea, constipation, and an 
increase of alanine transaminase (ALT ) 
dan aspartate transaminase (AST) of the 
liver.
3
 These side effects  has prompted 
researchers to seek alternatives other than 
statin. Secondary metabolites that have 
been reported as HMG-CoA reductase 
inhibitors were alkaloids and flavonoids.
4
 
Sungsuk et al  reported cholesterol reducing 
activity by quercetin of plant forest Allium 
victorialis.
5 
 
Administration of Guazuma ulmifolia 
leaves extract  mixture to hyperlipidemic 
rats has been reported to reduce  the rats’ 
liver total cholesterol concentration6 as well 
as the lipid peroxide content.7 No reports 
regarding the effect of Antocephalus 
macrophylus on cholesterol metabolism, 
only recent report by Cruz JP on the  
antimicrobial activity of the alcoholic 
extract of the leaves.8 Others have reported 
the antioxidant activity of its leaves and 
fruits.9  Similarly, methanolic leaf extract of 
Melia azedarach has been shown to posses 
antioxidant activity and the bark extract 
was shown to be highly bioactive with very 
small LC50 on BSLT assay.  No reports was 
found on the anticholesterol activity of M. 
azedarach. 
Since scientific informations on 
medicinal plants of Indonesian forest that 
are potential or that has been used 
traditionally for therapy of cardiovascular 
disease is still limited, this study was 
carried out to explore the potency of  jati 
belanda (G.ulmifolia), jabon merah 
(A.macrophyllus), and mindi (M.azedarach) 
leaves extracts as inhibitors of HMG-CoA 
reductase using in vitro assay and to 
identify the most active metabolite. 
 
METHODS 
Samples preparation  
Dried leaves for this study has been 
prepared as reported by Sulistiyani et al. 10 
Sampling method was conducted using a 
Farmakope Herbal Indonesia procedure.11 
Samples (Biopharmaca Research Center, 
Bogor, Indonesia) were dried at 50oC. 
Then, dried leaves were mashed into 40 
mesh. 
 
Tools and materials 
 High performance liquid chromato- 
graphy (HPLC), liquid chromatography- 
Mass spectrometry and tandem mass 
spectrometry (LC-MS/MS), methanol 
(Merck), ethanol (Merck), chloroform 
(Merck), standard gallic acid, standard 
quercetine , standard rutine, jati belanda (G. 
ulmifolia) leaf powder, jabon merah (A. 
macrophyllus) leaf powder, and mindi (M. 
azedarach) leaf powder from Biopharmaca 
Research Center, Bogor, Indonesia. 
 
Flavonoid extraction 
A total of 100 g leaf powder was 
macerated in methanol:ethanol (1:10) for 
2x24 h to produce filtrate. Subsequently, 
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the extract was partitioned using n-hexane 
(3x50 mL) that gave n-hexane fractions and 
residue. Then, the residue was fractioned 
with chloroform (3x50 mL) to obtain 
flavonoid extract.10 
  
HMG-CoA reductase activity assay 
The activity of the enzyme was 
analyzed using assay kit of HMGR from 
Sigma Aldrich with catalog number 
CS1090. This kit contains a buffer solution, 
NADPH as coenzyme, substrate solution 
(HMG-CoA), HMGR enzyme (EC 
1.1.1.34, 0.5-0.7 mg/mL), and inhibitor 
solution (pravastatin). 1 mL of samples 
with various concentrations (5-20 ppm) 
were added into the microplate. For 
comparison, quercetine at 5 ppm was used. 
Aliquots of buffer solution were added until 
final volume of 200 µL. Subsequently, 
NADPH (4 µL), HMG Co-A (12 µL), and 
HMGR (2 µL) were added into wells of 
control enzyme, samples, inhibitory, and 
blanks, respectively. Inhibition of the 
enzyme activity was measured with a 
microplate Reader spectrophotometer every 
20 seconds for 10 minutes at 37ºC and 
wavelength of  340 nm.12 
  
Analysis of antioxidant activity 
All samples and standard were spotted 
on thin layer chromatography (TLC) plates 
using silica gel as stationary phase and 
hexane: chloroform: methanol (4:3:3) as 
mobile phase. After fractions were 
developed, DPPH solution (4 mg/10 mL 
MeOH) was sprayed into TLC plates. A 
yellowish spots that appeared on the spot is 
an indication for antioxidant activity.13 
  
Total phenolic content determination 
The concentration of phenolics in plant 
extracts was determined using 
spectrophotometric method. The reaction 
mixtures was prepared by mixing 0.5 mL of 
sample, 2.5 mL of 10% Folin Ciocalteu 
reagent, and 2.5 mL of 7.5% Na2CO3 were 
prepared. The samples were incubated in a 
waterbath at 450C for 45 minutes. The 
absorbance was determined using 
spectrophotometer at λmax=765 nm. Gallic 
acid was used as the standard (one type of 
phenolic coumpond).14 
 
Total flavonoid content determination 
Sample mixtures which consisted of 0.2 
gram extract, 1 mL heksametil- entetramin 
(HMT), 20 mL acetone, and 2 mL of HCl 
25% were prepared and then these mixtures 
were refluxed for 30 minutes. Each mixture 
was filtered and acetone was added up to a 
volume of 100 ml using volumetric flask, 
after which it was poured into separation 
funnel wich has been filled with water in 
equal volume. This mixture was extracted 
with ethyl acetate (3 x 15 mL, and the ethyl 
actetate fraction was collected and made up 
to a volume of 50 mL. A total of 10 mL of 
this fraction was mixed with 1 mL of AlCl3  
and the volume was added up to 25ml with 
acetic acid glacial,  and was kept in room 
temperature for 30 minutes.  The samples 
absorbance was read at 425 nm wavelength 
using quercetin as the standard.15 
 
Concentration of quercetin analysis with 
high performance liquid chromato- 
graphy (HPLC) 
Quercetin content in the samples was 
analyzed quantitatively by reversed 
phase-high performance liquid 
chromatography (RP-HPLC). RP-HPLC 
analysis was performed by isocratic elution 
with a flow rate of 1.0 mL/min. Methanol 
was used as mobile phase. The injected 
volume of samples was 5 µL, while the 
detection wavelength was 370 nm. 
Standard quercetin was prepared in a 
various concentration series (5 
concentrations).16 
 
Analysis of marker compounds with 
liquid chromatography -mass 
spectrometry and tandem mass 
spectrometry (LC-MS/MS) 
Marker compounds from flavonoid 
extracts was analyzed by LC-MS/MS. 
LC-MS/MS analysis was performed by 
gradient elution with a flow rate of 0.3 
mL/min. Methanol & water was used as 
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mobile phase. The injected volume of 
samples was 5 µL.
17
 
 
RESULTS AND DISCUSSIONS 
Flavonoids extract yield 
Flavonoids were fractionated separately 
from the crude methanolic and ethanolic- 
extracts after partitioning the non-polar and 
semi-polar compounds with n-hexane and 
chloroform. The yields of six different 
flavonoids extracts was shown in Table 1. 
The highest yield of flavonoid value 
obtained from the methanolic extract was 
that of  A. macrophyllus (29.23%). This was 
higher than the one obtained from the 
ethanolic extract (18.32%). The highest 
yields were obtained from those 
fractionated from the methanolic extracts 
which suggested that the methanol 
extracted flavonoids compounds more than 
the ethanol. The flavonoid yields from the 
ethanolic extracts were consistenly lower 
than their crude extract yield as previously 
reported by Riki
18
 who reported the yield of 
the crude ethanolic leaf extracts of G. 
ulmifolia, A. macrophyllus, and M. 
azedarach were: 11.67%, 21.69%, and 
26.96%, respectively. 
 
Tabel 1 Recovery of flavonoid extracts 
Sample 
% Recovery 
(MeOH 
fraction) 
% Recovery 
(EtOH 
fraction) 
G.ulmifolia 12.60 11.13 
A.macrophyllus 29.23 18.32 
M.azedarach 24.44 18.66 
 
Inhibition of HMG-CoA reductase 
activity by flavonoids extracts 
The enzyme HMGR catalyzes the 
reduction of hydroxy-3-methyl-glutaryl- 
CoA (HMG-CoA) into coenzyme A (CoA) 
and mevalonate, which is a highly regulated 
reaction in cholesterol biosynthesis. There 
were quite a number of works have been 
done in search of substances with inhibitory 
action against the HMGR activity. Their 
targets mostly were to discover HMG-CoA 
analogs and to seek out its competitive 
inhibitor of the enzyme19. Table 2 shows the 
inhibitory activity of the  methanolic 
flavonoid fractions of several herbals in 
various concentrations against the HMGR 
(Table 2). All flavonoid extracts were 
shown to inhibit the HMGR 
(63.12-96.45%). Flavonoids leaf extracts of 
G.ulmifolia, however, were the best HMGR 
inhibitor out of the three plants 
(79.85-94.42%) when compared to the 
other two extracts which showed lower 
inhibitory activity (~ 60%). This findings 
are consistent with the previous works by 
Sulistiyani et al.10 WHO reported that 
methanolic flavonoid extracts of G. 
ulmifolia leaves at concentration of 20 ppm 
was able to inhibit the HMGR activity with 
the highest inhibitory activity compared to 
those of A.macrophyllus and M.azedarach. 
In preparation for future product 
development, however, the use of ethanolic 
flavonoid extracts are preferable for further 
studies in order to follow the safety 
regulation by Indonesian Ministry of 
Health.  Thus, to provide additional 
information regarding the flavonoids 
contained in the ethanolic extracts,  
qualitative DPPH test was carried out using 
catechin, naringin, and rutin as flavonoid 
standards; and  2,3-dihydroxy benzoic acid,  
2,6-dihydroxy benzoic acid,  and 3,6- 
dihydroxy benzoic acid as phenolic 
standards. Figure 1 shows that the ethanolic 
flavonoid extract of G. ulmifolia was potent 
antioxidant compare to others. The 
presence of antioxidant compounds was 
detected by yellow spots against the purple 
background on TLC plates as described by 
Masoko & Eloff.20 Based on the standard, 
there were various flavonoids in 
G.ulmifolia ethanolic extract, which 
include: rutin (a glycoside of a flavonol 
quercetin),  catechin (a flavanol),  naringin, 
as well as the phenols 2,3-dihydroxy 
benzoic acid and  dan 3,6-dihydroxy 
benzoic acid. The other two extracts also 
contain antioxidant activity, only to a lesser 
degree. Based on this finding and other 
data,  flavonoid of G. ulmifolia from 
ethanolic extract was selected for further 
study.   
Figure 2 showed the inhibitory action of 
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the flavonoid of G.ulmifolia ethanolic 
extracts in various concentrations 
compared to pravastatin control and 
quercetin standard. In our system, the 
pravastatin control inhibited 73.91% of 
HMGR activity, while quercetin showed 
slightly less inhibitory activity (69.56%). 
Pravastatin is a commercially available 
derivate of statin, a compound known 
originally as the HMGR inhibitor. Statin 
inhibited HMGR due to its molecular 
similarity to mevalonate, which is the 
product of the enzyme reaction catalyzed 
by the enzyme. By way of feed-back 
inhibition mechanism, this enzyme 
inhibiton will  result in  the cholesterol 
synthesis being blocked. Statin competes 
with the substrate to occupy the active site 
of the HMGR and changes the 
conformation of the enzyme. 
The inhibitory actions of the flavonoid 
extracts on HMGR activity was varied, 
ranging from 45.65% up to 82.8%. The 
extract with 10 ppm concentration showed 
highest inhibitory activity, which is also 
higher than those of pravastatin control and 
quercetin. Interestingly, this inhibitory 
activity was lower when the extract 
concentration was increased to 20 ppm.    
This phenomenon could be due to 
component interaction since the samples 
were still a mixture of crude flavonoids 
which contain  various type of flavonoids 
with different action.  The HMGR 
inhibitory effect of flavonoids in this study 
is consistent with a previous study by 
Sungsuk et al.5. They reported that leaf 
extract of Allium victorialis, a type of wild 
onions grown in the forest area, could 
inhibit HMGR activity by 73.9%.  in this 
study, quercetin and kaempferol isolated 
from the plant extract were shown to inhibit  
the HMGR gene expression using reverse 
transcriptase-polymerase chain reaction 
(RT-PCR). It was concluded that both 
compounds inhibited the cholesterol 
biosynthesis at the mRNA level. 
 
Tabel 2. HMGR inhibitory activity of the flavonoid extracts (MeOH fraction) 
Sample 
Consentrations (ppm) 
5 7.5 10 15 20 
G.ulmifolia 83.65% 79.85% 93.54% 94.42% 92.01% 
A.macrophyllus 69.96% 82.89% 76.42% 91.25% 88.97% 
M.azedarach 85.17% 91.63% 90.87% 96.45% 63.12% 
 
 
 
Figure 1. Antioxidant activity of flavonoid extracts (EtOH fraction) (1) catechin  
(2) naringin, (3) rutin, (4) G.ulmifolia, (5) A.macrophyllus, (6) M.azedarach, (7) 2,3- 
dihydroxy benzoic acid, (8) 2,6-dihydroxy benzoic acid, (9) 3,6-dihydroxy benzoic acid 
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Figure 2. Inhibitory action of the ethanolic flavonoid extracts of G. ulmifolia leaves 
against HMGR activity 
 
Identification of active compounds 
Total phenolic and flavonoid contents 
The total phenolic content of the 
samples was determined using gallic acid as 
the standard (standard curve equation: y = 
0.0079x + 0.0125, r2 = 0.9997). The 
phenolic contents were ranging from 10.00 
mg to 34.83 mg gallic acid equivalent/g 
dried leaves  (Table 3) with the flavonoid 
extract of A. macrophyllus being the extract 
with the highest phenolic content, and the 
lowest content was that of G.ulmifolia. 
Total flavonoids of the plant ethanolic 
extracts was determined using quercetin as 
the standard (standard curve equation:  y = 
0.1004×-0.0065, r2=0.9997). The flavonoid 
contents were ranging from 0.221 mg to 
0.777 mg quercetin equivalent /g dried 
leaves (Table 4). Similar to phenolic data, 
G.ulmifolia had the lowest quercetin 
content. This observation was consistent 
with previous report by Sulistiyani et al.10 
which showed that methanolic flavonoid 
extract of G.ulmifolia had the lowest 
quercetin content among those three 
samples.  Thus, the inhibitory action of the 
extracts was not correlated with the 
quercetin content. Taken together, these 
data indicate that the HMG-CoA reductase 
inhibitory effect of G.ulmifolia may not be 
mainly due to the quercetin compound nor 
its glycoside. 
 
Table 3 Total phenolic contents 
Sample Absorbance 
Extract’s 
weights 
(mg) 
Dried 
leaves’ 
weights (g) 
Gallic Acid 
(mg GAE/L) 
Total phenolic 
(mg GAE/g dried 
leaves) 
G.ulmifolia 0.190 ± 0.009 2.5 0.001123 22.47  10.00 ± 0.534 
A.macrophyllus 0.403 ± 0.003 2.6 0.000709 49.43  34.83 ± 0.272 
M.azedarach 0.163 ± 0.013 2.6 0.000697 19.05 13.67 ± 1.156 
 
Table 4 Total flavonoid contents 
Sample Absorbance 
Extract’s 
weights 
(mg) 
Dry leaves’ 
weights (g) 
Quercetin 
(mg QE/L) 
Total flavonoid 
(mg QE/g dried 
leaves) 
G.ulmifolia 0.043 ± 0 0.1548 1.391 0.49 0.22 ± 0 
A.macrophyllus 0.081 ± 0.003 0.1906 0.850 0.87 0.64 ± 0.025 
M.azedarach 0.121 ± 0.001 0.1558 1.022 1.27 0.78 ± 0.006 
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HPLC analysis of  the flavonoid extracts   
The RP-HPLC was carried out using 
nonpolar immobile phase (C18 column) 
and polar (MeOH) mobile phase and 
quercetin as the standard.  The quercetin 
detection wavelength was 370 nm. The 
retention time for quercetin standard (1000 
ppm) was 2.882 minutes (Figure 3).The 
concentrations of quercetin in the ethanolic 
flavonoid extracts were calculated using the 
peak area in the similar retention time as 
shown in Table 5.  The amount of quercetin 
in the three extracts (1000 ppm) were 
ranging from 65.99 ppm to 70.41 ppm 
indicating that quercetin may not be the 
major active compound responsible for the 
HMG-CoA inhibitory action in G.ulmifolia 
flavonoid extract. The small amount of 
quercetin in the ethanolic extracts of 
flavonoid is accountable for since most of 
the nonpolar flavonoids was already 
removed during the extraction process. 
There is a possibility that rutin, the polar 
glycoside form of quercetin, might be the 
active component in the ethanolic flavonoid 
extract; the answer to which will await 
further investigation. 
 
Identification of active component with 
LC-MS/MS.   
Analysis of LC-MS /MS chromatogram 
shows that the sample demonstrated  more 
than one peak (Figure 4). Further analysis 
showed that the extract contained several 
compounds, but the largest one in the 
sample has a molecular weight of 380.0723 
Da  (Figure 5).  This method of 
identification, however, was showing only 
the weight and possible formula, and was 
not able to  predict the exact active 
compound. Further analysis of the 
compound need to be done using NMR 
instrument in the future. 
 
Table 5 Quercetin content of the ethanolic extracts. 
Flavonoid Extracts Area Quercetin content (%) 
G.ulmifolia (1000 ppm) 37248 6.7 
M.azedarach (1000 ppm) 109550 7.0 
A.macrophyllus (1000 ppm) 13857 6.6 
 
 
 
 
Figure 3. Chromatogram of quercetin standard (1000 ppm) 
 
 
M in u te s
0 2 4 6 8 1 0 1 2 1 4
V
o
lt
s
0 .0
0 .5
1 .0
1 .5
V
o
lt
s
0 .0
0 .5
1 .0
1 .5
0
.
8
4
0
1
.
9
9
8
2
.
1
4
0
2
.
4
8
0
2
.
8
8
2
1
0
.
1
5
7
1
1
.
3
2
2
1
1
.
6
1
7
1
1
.
7
4
2
1
2
.
8
3
7
D e te c to r  A  (3 7 0 n m )
A rth u r
s td  1 0 0 0  p p m
R e te n tio n  T im e
Jurnal Kefarmasian Indonesia. 2017;7(2):95-104 
 
102 
 
 
Figure 4. Chromatogram of G.ulmifolia flavonoid extract 
 
Figure 5. Result analysis with LC-MS/MS 
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138.0550104.1116
82.0219
32.1095
293.0548266.1152219.0199
139.0580
365.0967
337.0810
455.1122
382.0753
411.0908 543.1322
456.1153 525.1655 723.2033707.2195617.1733557.1555
!
635.1827
797.1371
743.1929 824.1575 !
1065.3187899.2832
!
973.2173
953.2239
1049.3311 1139.2474
!
1166.2612
Shelly - Jati Belanda F Met Air 6 min 1 (0.034) 1: TOF MS ES+ 
1.00e5114.0943
84.967032.9275
141.9576 172.9728
391.2767
371.3069214.0829
279.1491
299.1171
403.2252
!
807.3569
!
449.1026 !
659.2598
!
638.2023
551.7596478.3458
!
738.2410699.5102
!
877.1665
!
1013.1198
!
898.9080
954.8259
!
1155.9888
!
1124.0780
!
1080.2185
!
1176.5417
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CONCLUSION 
Methanolic flavonoid extract of 
G.ulmifolia showed the best potency as 
inhibitor of HMG-CoA reductase compared  
to those of A.macrophyllus and M. 
azedarach.  For product development 
purpose, however, the ethanolic flavonoid 
extract of G. ulmifolia was selected for 
further analyses. This ethanolic flavonoid 
extract of G.ulmifolia was shown to contain 
more potent antioxidant activity than the 2 
other extracts. The in vitro assay data 
consistently showed that this extract has the 
ability as HMGR inhibitor as well as 
pravastatin at concentration  of 10 ppm 
(82.6%). HPLC analysis showed that all 
samples contain quercetin at similiar small 
concentrations (6.7%, 6.6%, and 7.0% for 
G. ulmifolia, A. macrophyllus, and M. 
azedarach, respectively). Thus indicating 
other active compounds may play some 
roles in this inhibitory action on HMG-CoA 
reductase activity. Further identification 
using LC-MS/MS showed that G. ulmifolia 
flavonoid extract contained an unidetified 
coumpound with molecural weight of 
380.0723 Da. 
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